Apart from surgical excision and radiotherapy, systematic chemotherapy in adjuvant setting has been proved to bring about noticeable benefit in OS and DFS of elderly breast cancer women, particularly in hormone receptor (HR)-negative cohorts. The gene discussed is NR4A1; the disease is breast carcinoma.